New Themed Issue "Epigenetics" in MedChemComm

MedChemComm is delighted to publish this collection of articles in the emerging field of epigenetics research, guest edited by Dr Mark Bunnage (Pfizer) and Professor Rasmus Prætorius Clausen (University of Copenhagen).

[ more ... ]   

Since October 1st 2011 Prof. Wolfgang Sippl is visiting professor at the FRIAS (Freiburg Institute for Advanced Studies) of the Freiburg University.

[ more ... ]   

Funding of a new interdisciplinary research cluster "Structure-based epigenetic drug discovery"

The FRIAS at the University of Freiburg is funding a new  interdisciplinary research cluster focussing on “Structure-based Epigenetic Drug Discovery”.

The applicants will  establish the foundation for structure-based epigenetic drug  discovery in Freiburg based upon their expertises in structural  biochemistry (Prof. Oliver Einsle; Univ. Freiburg), medicinal chemistry (Prof. Manfred  Jung, Univ. Freiburg) and cheminformatics (Prof. Wolfgang Sippl, MLU Halle-Wittenberg). Based on the close  interaction of the individual research areas a number of lead structures  for epigenetic targets will be developed and made available for further  biological characterization.

The Freiburg Institute for  Advanced Studies (FRIAS) is the University of  Freiburg’s international  research college. It was established after  Freiburg’s success in the  Federal Excellence Initiative in October 2007.

[ more ... ]   

Wettlauf gegen die Resistenz

Campus News in der Mitteldeutschen Zeitung

[ more ... ]   

Developmemt of an open-source protein-ligand docking platform

The software ParaDockS is a framework for molecular docking.

[ more ... ]

Development of novel drug leads for schistosomiasis therapy: researchers from Halle involved in EU FP7 project

EU is funding an internationales project with 3.3 Million Euro

[ more ... ]